Boston ScientificMEX:BSX 83 FCF Margin % is 3.29% as of Mar. 2026, which is 71% below its 10-year median of 11.25. GuruFocus rates MEX:BSX with a GF Score™ of 83/100 and a GF Value™ of MXN1,849.68 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Boston Scientific ranks better than 85.4% on this metric.
The historical rank and industry rank for Boston Scientific's FCF Margin % or its related term are showing as below:
MEX:BSX'
s FCF Margin % Range Over the Past 10 Years
Min: -1.81 Med: 11.25 Max: 16.96
Current: 16.15
During the past 13 years, the highest FCF Margin % of Boston Scientific was 16.96%. The lowest was -1.81%. And the median was 11.25%.
MEX:BSX's FCF Margin % is ranked better than 85.4% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs MEX:BSX: 16.15
Boston Scientific FCF Margin % Related Terms
Boston Scientific FCF Margin % Historical Data
* Premium members only.
The historical data trend for Boston Scientific's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Boston Scientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Boston Scientific's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a FCF Margin % of 3.29% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Boston Scientific and its competitors. This is 71% below median its historical median of 11.25. According to the industry distribution chart, Boston Scientific ranks #119 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 14.6%.
Is Boston Scientific's FCF Margin % too high?
Boston Scientific's current FCF Margin % of 3.29% is 71% below median its 10-year median of 11.25. Based on the distribution chart, Boston Scientific ranks #119 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Boston Scientific has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's FCF Margin % compare to EW and MDT?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #119 out of 815 companies for FCF Margin %. This places Boston Scientific in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Boston Scientific and its competitors. Boston Scientific's current FCF Margin % is 3.29%, which is 71% below median its own 10-year median of 11.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,849.68, compared to a current price of MXN790.00 — trading 57.3% below its estimated fair value. The current FCF Margin % is 3.29%, which is 71% below median its 10-year median of 11.25. Boston Scientific's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current FCF Margin % is 3.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN790.00 is trading 57.3% below its estimated GF Value™ of MXN1,849.68.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
FCF Margin %: 3.29% (71% below median its 10-year median of 11.25)
GF Value™: MXN1,849.68 vs. price of MXN790.00 (57.3% below fair value)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
83GF Score
Get the complete analysis for MEX:BSX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
